Correlation Between Pfizer and JPMorgan Chase

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and JPMorgan Chase at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and JPMorgan Chase into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc CDR and JPMorgan Chase Co, you can compare the effects of market volatilities on Pfizer and JPMorgan Chase and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of JPMorgan Chase. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and JPMorgan Chase.

Diversification Opportunities for Pfizer and JPMorgan Chase

-0.87
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Pfizer and JPMorgan is -0.87. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc CDR and JPMorgan Chase Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on JPMorgan Chase and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc CDR are associated (or correlated) with JPMorgan Chase. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of JPMorgan Chase has no effect on the direction of Pfizer i.e., Pfizer and JPMorgan Chase go up and down completely randomly.

Pair Corralation between Pfizer and JPMorgan Chase

Assuming the 90 days trading horizon Pfizer Inc CDR is expected to under-perform the JPMorgan Chase. In addition to that, Pfizer is 1.04 times more volatile than JPMorgan Chase Co. It trades about -0.07 of its total potential returns per unit of risk. JPMorgan Chase Co is currently generating about 0.09 per unit of volatility. If you would invest  1,754  in JPMorgan Chase Co on September 24, 2024 and sell it today you would earn a total of  1,402  from holding JPMorgan Chase Co or generate 79.93% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Pfizer Inc CDR  vs.  JPMorgan Chase Co

 Performance 
       Timeline  
Pfizer Inc CDR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc CDR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.
JPMorgan Chase 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in JPMorgan Chase Co are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, JPMorgan Chase displayed solid returns over the last few months and may actually be approaching a breakup point.

Pfizer and JPMorgan Chase Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and JPMorgan Chase

The main advantage of trading using opposite Pfizer and JPMorgan Chase positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, JPMorgan Chase can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in JPMorgan Chase will offset losses from the drop in JPMorgan Chase's long position.
The idea behind Pfizer Inc CDR and JPMorgan Chase Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account